Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | NAMPT | P43490 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | NQO2 | P16083 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2843187 | 0.85 | KMT2A (0.57) | MEN1KMT2AGAACYP3A4LMNA | |
| SCHEMBL16930373 | 0.83 | CNR2 (0.48) | CA1CA2NAMPTMEN1KMT2A | |
| SCHEMBL6859689 | 0.83 | ALDH1A1 (0.56) | CA1CA2KMT2ACA12CA9 | |
| SCHEMBL6815439 | 0.81 | CA2 (0.55) | CA1CA2MEN1KMT2ACA12 | |
| SCHEMBL25300742 | 0.81 | MTNR1A (0.56) | NAMPTMEN1KMT2ALMNA | |
| SCHEMBL30517507 | 0.81 | MTNR1A (0.56) | NAMPTMEN1KMT2ALMNA | |
| SCHEMBL31432851 | 0.80 | CA12 (0.64) | CA1CA2MEN1KMT2AGAA | |
| SCHEMBL903446 | 0.80 | CA12 (0.64) | CA1CA2MEN1KMT2AGAA | |
| SCHEMBL6537275 | 0.76 | MTNR1A (0.59) | CA1CA2MEN1KMT2ACA12 | |
| SCHEMBL19742789 | 0.76 | MTNR1A (0.58) | MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020032080-A1 | COMPOUND, SALT OF COMPOUND, NEUROMODULATION AGENT, METHOD FOR EVALUATING NEUROMODULATION AGENT, METHOD FOR PRODUCING COMPOUND, AND METHOD FOR PRODUCING SALT OF COMPOUND | 学校法人慶應義塾 | 2020-02-13 | — | — | WO | disclosed |